Palmitoylethanolamide (PEA) vs R-Alpha Lipoic Acid

Side-by-side comparison of mechanisms, dosing, interactions, and stacking potential.

Palmitoylethanolamide (PEA)R-Alpha Lipoic Acid
CategorySupplementsSupplements
Standard Dose
Timing
Cycle Duration
Evidence LevelStrongModerate

Mechanism

Endocannabinoid-like lipid that activates PPAR-alpha and indirectly enhances endocannabinoid tone. Potent anti-inflammatory and analgesic without acting directly on CB1/CB2. Reduces mast cell activation, neuroinflammation, and chronic pain.

Contraindications

  • None established at standard doses

Mechanism

Redox-active cofactor that supports mitochondrial dehydrogenase complexes, glutathione recycling, and glucose disposal.

Contraindications

  • Monitor in clients prone to hypoglycemia

Not sure which is right for you?

Take our free assessment to get personalized recommendations based on your health goals, current stack, and biomarkers.

Get Your Free Protocol →or take the assessment →